Hanugen

Developer of oligonucleotides to treat muscular dystrophy

placeBengaluru, Karnataka, India calendar_todayFounded 2017 language hanugen.com

Registered entities

Investor mix

4 investors on record.

Investor typeCountShare
Accelerator & incubator125%
Other / undisclosed375%
Coming soon